Altimmune Inc [ALT] fell -36.53% so far this year. What now?

Altimmune Inc [NASDAQ: ALT] stock went on an upward path that rose over 11.39% on Monday, amounting to a one-week price increase of more than 16.86%.

Over the last 12 months, ALT stock rose by 71.63%. The one-year Altimmune Inc stock forecast points to a potential upside of 65.29. The average equity rating for ALT stock is currently 1.50, trading closer to a bullish pattern in the stock market.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The market cap for the stock reached $506.23 million, with 70.68 million shares outstanding and 70.35 million shares in the current float. Compared to the average trading volume of 3.21M shares, ALT stock reached a trading volume of 22435116 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Altimmune Inc [ALT]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ALT shares is $20.57 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ALT stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Guggenheim have made an estimate for Altimmune Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on April 29, 2024. While these analysts kept the previous recommendation, Goldman raised their target price to Neutral. The new note on the price target was released on January 24, 2024, representing the official price target for Altimmune Inc stock. Previously, the target price had yet another drop from $20 to $6, while Goldman kept a Neutral rating on ALT stock.

The Average True Range (ATR) for Altimmune Inc is set at 0.64, with the Price to Sales ratio for ALT stock in the period of the last 12 months amounting to 1234.70. The Price to Book ratio for the last quarter was 2.93, with the Price to Cash per share for the same quarter was set at 2.57.

ALT Stock Performance Analysis:

Altimmune Inc [ALT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 16.86. With this latest performance, ALT shares dropped by -9.51% in over the last four-week period, additionally sinking by -10.53% over the last 6 months – not to mention a rise of 71.63% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ALT stock in for the last two-week period is set at 53.80, with the RSI for the last a single of trading hit 60.80, and the three-weeks RSI is set at 50.37 for Altimmune Inc [ALT]. The present Moving Average for the last 50 days of trading for this stock 7.16, while it was recorded at 6.26 for the last single week of trading, and 6.83 for the last 200 days.

Insight into Altimmune Inc Fundamentals:

Altimmune Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 16.55 and a Current Ratio set at 16.55.

Altimmune Inc [ALT] Institutonal Ownership Details

The top three institutional holders of ALT stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in ALT stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in ALT stock with ownership which is approximately 5.8386%.